Medify Solutions Ltd. (Pink Sheets: MFYS) Announces Latest Business Developments With Oracle and Revenues
Gateshead, England (ots/PRNewswire)
Remote Technology Company Medify Solutions (Pink Sheets: MFYS) is delighted to announce its expansion into the European market with Oracle as business partner, the world's largest enterprise software company. Following the positive collaborative achievements of Medify with Oracle on the NHS project, Oracle will support Medify Solutions Ltd in its European expansion.
Medify is going live as announced to its NHS customers on the 1st of September 2006. There are approximately 1.4m NHS employees and circa 500 000 healthcare professionals working for the NHS.
The first roll out site is for approximately 2500 users (US85 per customer per month for two years with an expected revenue stream of US5.1m).
The company will float its European subsidiary on the Frankfurt Exchange, the announcement to follow shortly. This expansion is supported, as announced by Oracle, the world's largest enterprise software company.
Medify does have an exclusive contract with EMIS to provide its technology to EMIS users. Currently EMIS supplies its service to 60% of the NHS UK primary care market (circa 150 000 healthcare professionals).
Medify has commercial activities in place in the European market justifying the impending floatation.
Medify Press Office: press@medifysolutions.com
Company Website: www.medifysolutions.com
This press release was constructed in conjunction with StockTargets Inc. http://www.stocktargets.com
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
Contact:
For further information: Jonathan Bryant, Group Chairman, Medify
Solutions, Tel: +44-(0)-845-034-4090, Fax: +44-(0)-1785-214474,
jbryant@medifysolutions.com/